Literature DB >> 12678737

The molecular mechanisms for the antitumorigenic effect of curcumin.

Tzeng-Horng Leu1, Ming-Chei Maa.   

Abstract

Curcumin, an active yellow pigment of turmeric and curry, possesses anti-inflammatory, antioxidative and anticarcinogenic properties. Analysis of its structure revealed the presence of beta-diketone moiety and phenolic hydroxy groups that were believed to contribute to antioxidation. And vanillin, ferulic acid and a dimer of curcumin were identified as the curcumin-derived radical reaction products. In addition to antioxidation, curcumin could also induce apoptosis by targeting mitochondria, affecting p53-related signaling and blocking NF-kappaB activation. To further dissect its anticarcinogenic mechanisms, a number of curcumin targets were identified. These included the aryl hydrocarbon receptor, cytochrome P450, glutathione S-transferase, serine/threonine kinases, transcription factors, cyclooxygenase, ornithine decarboxylase, nitric oxide synthase, matrix metalloproteinases and tyrosine kinases. This review will summarize our current knowledge on how these important proteins are affected by curcumin, and hopefully, may provide a whole picture illustrating how the chemopreventive and antitumorigenic effect of curcumin is achieved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12678737     DOI: 10.2174/1568011024606370

Source DB:  PubMed          Journal:  Curr Med Chem Anticancer Agents        ISSN: 1568-0118


  27 in total

Review 1.  Colorectal cancer: chemopreventive role of curcumin and resveratrol.

Authors:  Vaishali B Patel; Sabeena Misra; Bhaumik B Patel; Adhip P N Majumdar
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Studies on curcumin and curcuminoids. XLVI. Photophysical properties of dimethoxycurcumin and bis-dehydroxycurcumin.

Authors:  L Nardo; A Andreoni; M Bondani; M Másson; T Haukvik; H H Tønnesen
Journal:  J Fluoresc       Date:  2011-10-27       Impact factor: 2.217

3.  Synthesis and identification of new 4-arylidene curcumin analogues as potential anticancer agents targeting nuclear factor-κB signaling pathway.

Authors:  Xu Qiu; Yuhong Du; Bin Lou; Yinglin Zuo; Weiyan Shao; Yingpeng Huo; Jianing Huang; Yanjun Yu; Binhua Zhou; Jun Du; Haian Fu; Xianzhang Bu
Journal:  J Med Chem       Date:  2010-11-11       Impact factor: 7.446

4.  Anticancer effect of curcumin on human B cell non-Hodgkin's lymphoma.

Authors:  Chunyan Sun; Xinyue Liu; Yan Chen; Fang Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

5.  Antioxidant activity of a new aromatic geranyl derivative of the resinous exudates from Heliotropium glutinosum Phil.

Authors:  Brenda Modak; Macarena Rojas; René Torres; Jesús Rodilla; Federico Luebert
Journal:  Molecules       Date:  2007-05-21       Impact factor: 4.411

6.  Clinical comparison of dose calculation using the enhanced collapsed cone algorithm vs. a new Monte Carlo algorithm.

Authors:  Irina Fotina; Gabriele Kragl; Bernhard Kroupa; Robert Trausmuth; Dietmar Georg
Journal:  Strahlenther Onkol       Date:  2011-06-27       Impact factor: 3.621

Review 7.  Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

Authors:  Jayaraj Ravindran; Sahdeo Prasad; Bharat B Aggarwal
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

8.  Curcumin administration suppresses collagen synthesis in the hearts of rats with experimental diabetes.

Authors:  Shuang Guo; Xiang-Wen Meng; Xiao-Song Yang; Xiu-Fen Liu; Chang-Han Ou-Yang; Chao Liu
Journal:  Acta Pharmacol Sin       Date:  2017-09-14       Impact factor: 6.150

9.  Curcumin decreases the expression of Pokemon by suppressing the binding activity of the Sp1 protein in human lung cancer cells.

Authors:  Jiajun Cui; Xianfeng Meng; Xudong Gao; Guangxuan Tan
Journal:  Mol Biol Rep       Date:  2009-05-15       Impact factor: 2.316

10.  2-Deoxy-D-glucose and ferulic acid modulates radiation response signaling in non-small cell lung cancer cells.

Authors:  Venkata Reddy Bandugula; Rajendra Prasad N
Journal:  Tumour Biol       Date:  2012-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.